The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review
Open accessAbstract
The COVID-19 pandemic affected millions of people worldwide. In addition to respiratory impairment, this viral infection can also provoke gastrointestinal symptoms caused by vascular disorders, such as portal-splenic-mesenteric venous thrombosis (PSMVT). This systematic review aimed to investigate the profile of patients who developed PSMVT concomitant with or after viral infection and its predominant outcomes. The database searches returned 214 articles. Of these, 40 case reports were included in the review, presenting a total of 41 cases of PSMVT addressed. Males were more prevalent (n=27; 65.85%), mean age was 51.54 years, and 19.57% had a previous history of endocrine diseases. Statistically significant relationships (p<0.05) were found between patient death and tachypnea at hospital admission (p=0.043) and between patient death and age (p=0.019). It was therefore possible to identify the main profiles and risk factors for PSMVT development and mortality of COVID-19 infected patients.
Overview
CoChat Summary
TL;DR
This systematic review of 40 case reports (41 PSMVT cases) describes COVID-19 patients who developed portal-splenic-mesenteric venous thrombosis, finding male predominance, mean age 51.54 years, and significant associations between death and both tachypnea at admission and older age.
Most patients were discharged, but pre-discharge death occurred in 19.57% and post-discharge death in 6.52%.
Key findings
- The review included 40 case reports describing 41 PSMVT cases; males were more prevalent (n=27; 65.85%), mean age was 51.54 years (range 28–84), and 19.57% had a previous endocrine disorder.
- Statistically significant relationships were found between patient death and tachypnea at hospital admission (p=0.043) and between patient death and age (p=0.019).
- Outcomes included discharge in 30 patients (65.22%), pre-discharge death in 9 (19.57%), post-discharge death in 3 (6.52%), and complete cure in 12 (26.09%).
- Risk-of-bias scoring showed 22 of 41 case reports (53.66%) scored 6/6, 10 (24.39%) scored 5/6, and 9 (21.95%) scored 4/6 using an adapted Murad et al. tool.
Methods
- Systematic review following PRISMA, registered on PROSPERO (CRD42021286846), using case reports of patients with suspected/confirmed COVID-19 who later presented coagulation disorders, thrombus, or embolus involving the portal-splenic-mesenteric system.
- Searches were run in November 2021 in PubMed (MEDLINE), Web of Science, Scopus, LILACS, Cochrane Library, and SciELO, with no date limits; 214 articles were found, 71 selected for final screening, and 40 case reports included.
- Data extraction covered patient characteristics, symptoms, laboratory/imaging findings, treatment, and outcomes; risk of bias was assessed with Murad et al. criteria, and analyses used descriptive statistics plus Shapiro-Wilk, Mann-Whitney U, Chi-square, or Fisher Exact tests in R 4.0.4, with p<0.05 considered significant.
Limitations
- The paper states that because reviewed papers were published early in the pandemic, the number of studies found was limited, and the literature available at the time did not include many publications on COVID-19 vaccination.
- The paper states that some studies correlating PSMVT with vaccinated patients were excluded because they did not meet inclusion criteria, and that case reports often had incomplete or partial data, hampering analysis.
- Evident from the text: the review relies solely on case reports, did not set a cutoff score for methodological quality, and cannot establish causality or generalizable incidence from the included data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
14 Valid · 4 Not valid · 14 Not checked · 69 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This association is mainly due to the effects that cardiovascular diseases such as hypertension, along with the viral infection, tend to provoke on the vascular homeostatic system, promoting an inflammatory and turbulent environment that favors the emergence of a pre-thrombotic process that might lead to PSMVT.3”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > DISCUSSION
What the sources say
- Partly supportedcites [3] Pang JHQ, 2021, A peculiar case of small bowel stricture in a coronavirus disease 2019 patient with congenital adhesion band and superior mesenteric vein thrombosis, Ann Vasc Surg sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cheruiyot et al.54 also identified higher prevalence of deep venous thrombosis in male and older COVID-19 infected patients.”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > DISCUSSION
What the sources say
- Partly supportedcites Cheruiyot et al.54 Cheruiyot I, 2021, Arterial thrombosis in coronavirus disease 2019 patients: a rapid systematic review, Ann Vasc Surg sourceExperimental — accuracy not yet measured
The Results (Data Synthesis, ‘Age and Sex Distribution of Patients with AT’; page not provided) report that most patients with arterial thrombotic events were male and that few reported cases involved patients under 50. The finding concerns arterial thrombosis, not deep venous thrombosis, so the claimed event type is unsupported. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Thirdly, vascular stasis might be a consequence of the immobilization of patients severely affected by the disease.”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > INTRODUCTION
What the sources say
- Supportedcites [3] Pang JHQ, 2021, A peculiar case of small bowel stricture in a coronavirus disease 2019 patient with congenital adhesion band and superior mesenteric vein thrombosis, Ann Vasc Surg source
The Discussion states that blood stasis can result from immobilization in critically ill patients, matching the claim about patients severely affected by COVID-19. No page number is provided in our copy. (LLM, conf=0.94)
- Partly supportedcites [4] Parry AH, 2020, Acute mesenteric ischemia in severe coronavirus-19 (COVID-19): possible mechanisms and diagnostic pathway, Acad Radiol sourceExperimental — accuracy not yet measured
In the paper’s main text (page unavailable), immobilization is listed as a possible contributor to hypercoagulability and mesenteric vascular thrombosis in severe COVID-19. The paper does not specifically say that immobilization causes vascular stasis, so it supports the proposed role of immobilization but not the stated mechanism. (LLM, conf=0.82)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Other studies had already demonstrated the relationship between SMVT and previous cardiovascular disease (Strauss et al.50 and Guillet et al.51).”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > DISCUSSION
What the sources say
- Could not verifycites Strauss et al.50 Strauss SA, 2020, From cellular function to global impact: the vascular perspective on COVID-19, Can J Surg sourceExperimental — accuracy not yet measured
The Venous thromboembolism section discusses VTE in patients with COVID-19, and the Peripheral arterial thromboembolism section mentions a superior mesenteric artery occlusion. Neither addresses a relationship between SMVT and previous cardiovascular disease. Searches for SMVT and mesenteric venous thrombosis did not find a passage establishing that relationship in our copy. (LLM, conf=0.76)
- Could not verifycites Guillet et al.51 Guillet H, 2021, Clinical spectrum of ischaemic arterial diseases associated with COVID-19: a series of four illustrative cases, Eur Heart J Case Rep sourceExperimental — accuracy not yet measured
Case presentation 2 describes occlusion of the superior mesenteric artery, not superior mesenteric vein thrombosis (SMVT). The Discussion discusses cardiovascular risk factors in patients hospitalized with COVID-19, but neither it nor the searched passages on mesenteric vein thrombosis establish a relationship between SMVT and previous cardiovascular disease. (LLM, conf=0.77)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“An observational study by Ahmed et al.53 also reported a higher prevalence of men, since 29 of the 349 (60%) cases observed were men, while only 140 were female patients.”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > DISCUSSION
What the sources say
- Partly supportedcites Ahmed et al.53 Ali Ahmed SM, 2021, Peripheral vascular system thrombosis and COVID-19: a chilling revelation, Indian J Vasc Endovasc Surg. sourceExperimental — accuracy not yet measured
The Materials and Methods (Observations; article pp. 208–212) report 349 DVT patients, including 209 men and 140 women. Men therefore accounted for about 60%, but the citing sentence incorrectly says 29 men. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
32 more claims · 4 with their cited sources checked
Create a free account to see all 101 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 51
- It may state two separate claims as one. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“since 29 of the 349 (60%) cases observed were men”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > DISCUSSION
Reported 60 · recomputed 8.309456
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Previous endocrine disorder | 9 | 19.57 | 10.65 | 33.17 |”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > RESULTS > Patients’ characteristics
Reported 19.57 · recomputed 21.95122
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Constipation | Constipation | 5 | 14.63 | 6.88 | 28.44 |”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > RESULTS > Clinical conditions
Reported 14.63 · recomputed 12.195122
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Lack of appetite | Lack of appetite | 6 | 12.2 | 5.32 | 25.54 |”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > RESULTS > Clinical conditions
Reported 12.2 · recomputed 14.634146
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > RESULTS
“out of the 41 case reports evaluated”
§ Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review > RESULTS
“Forty of these were case reports included in the review, describing 41 cases of portal-splenic-mesenteric venous thrombosis (PSMVT)”
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Methodological quality and synthesis of case series and case reports
Murad, M. H., Sultan, S., Haffar, S., & Bazerbachi, F. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2017-110853 · Cited by 2,242
The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects
Bonanad, C., García-Blas, S., Tarazona-Santabalbina, F., Sanchis, J., Bertomeu-González, V., Fácila, L., Ariza, A., Núñez, J., & Cordero, A. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.05.045 · Cited by 730
Acute Mesenteric Ischemia: A Clinical Review
Oldenburg, W. A., Lau, L. L., Rodenberg, T. J., Edmonds, H. J., & Burger, C. D. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1054 · Cited by 714
Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review
Cheruiyot, I., Kipkorir, V., Ngure, B., Misiani, M., Munguti, J., & Ogeng'o, J. (2021) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.08.087 · Cited by 434
Harnik, I. G., & Brandt, L. J. (2010) · Vascular Medicine · doi:10.1177/1358863x10379673 · Cited by 210
Hmoud, B., Singal, A. K., & Kamath, P. S. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.03.052 · Cited by 160
Superior Mesenteric Artery Syndrome: Where Do We Stand Today?
Lee, T. H., Lee, J. S., Jo, Y., Park, K. S., Cheon, J. H., Kim, Y. S., Jang, J. Y., & Kang, Y. W. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2049-5 · Cited by 140
Parry, A. H., Wani, A. H., & Yaseen, M. (2020) · Academic Radiology · doi:10.1016/j.acra.2020.05.016 · Cited by 109
Research works printed but not linked: 1
- Marsafi O, 2021, Acute venous mesenteric ischemia in a young COVID-19 positive subject: a case report, Pan Afr Med J, 39, 273
Cited by
Mesenteric Ischemia: A Comprehensive Review of the Role of Radiology in Diagnosis
Pereira, S. I. D. S., Alshatti, A. A., Akoum, N. A., Rukh, S., Malik, N. Q., Ahmed, S., Kaur, R., & Siddiqui, H. F. (2025) · Cureus · doi:10.7759/cureus.90384 · Cited by 5
“Risk factors in these patients include pre-existing comorbidities, such as advanced age, diabetes mellitus, cardiac disease, and hypertension [18].”
Trombosis Venosa Portomesentérica como Complicación de Cirugía Bariátrica. A propósito de un caso.
Andia, F. N., Millar, J. J. O., Guilquiruca, G. M., Hernández, V. R., & Zablah, S. R. (2025) · Revista ANACEM. · doi:10.70536/revanacem/v19n1-202574
Metadata
- Authors
- Gomes, R. Z., Salina, M. V. J., Pironatto, V. H. M., Lepinski, J. K., Gueiber, T. D., Juliatto, B. M. S., Prestes, M. Z., & Martins, C. M.
- Affiliations
- Universidade Estadual de Ponta Grossa (BR)
- Corresponding author
- Pironatto, Vitor Hugo Moro
- ORCID
- Venue
- Jornal Vascular Brasileiro
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2025
- Volume
- 24
- Pages
- e20230128-e20230128
- ISSN
- 1677-5449 (ISSN-L)
- 1677-7301
- PMC
- PMC11815833
- OpenAlex
- W4407353294
- Cited by
- 2
- References
- 67
- Citations by year
- 2025: 2
- FWCI
- 0.26
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Jornal Vascular Brasileiro (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- COVID-19 pandemic, venous thromboembolism, risk factors, mortality, tachypnea, endocrine disorders, patient characteristics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review. https://app.cochat.ai/papers/10.1590/1677-5449.202301282
- The paper
- Gomes, R. Z., Salina, M. V. J., Pironatto, V. H. M., Lepinski, J. K., Gueiber, T. D., Juliatto, B. M. S., Prestes, M. Z., & Martins, C. M. (2025). Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review. Jornal Vascular Brasileiro. https://doi.org/10.1590/1677-5449.202301282
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


